Nordea Investment Management’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-84,951
| Closed | -$4.38M | – | 968 |
|
|
2026
Q1 | $4.38M | Buy |
+84,951
| New | +$5.1M | ﹤0.01% | 615 |
|
|
2025
Q3 | – | Sell |
-43,864
| Closed | -$2.27M | – | 880 |
|
|
2025
Q2 | $2.27M | Buy |
43,864
+7,582
| +21% | +$381K | ﹤0.01% | 710 |
|
|
2025
Q1 | $2.1M | Buy |
36,282
+24,491
| +208% | +$1.66M | ﹤0.01% | 692 |
|
|
2024
Q4 | $852K | Hold |
11,791
| – | – | ﹤0.01% | 827 |
|
|
2024
Q3 | $935K | Buy |
11,791
+332
| +3% | +$24.9K | ﹤0.01% | 814 |
|
|
2024
Q2 | $826K | Buy |
11,459
+960
| +9% | +$70.7K | ﹤0.01% | 827 |
|
|
2024
Q1 | $737K | Buy |
10,499
+5
| +0% | +$358 | ﹤0.01% | 862 |
|
|
2023
Q4 | $815K | Buy |
10,494
+761
| +8% | +$50.1K | ﹤0.01% | 849 |
|
|
2023
Q3 | $678K | Sell |
9,733
-627
| -6% | -$49.5K | ﹤0.01% | 875 |
|
|
2023
Q2 | $839K | Buy |
10,360
+577
| +6% | +$46.4K | ﹤0.01% | 841 |
|
|
2023
Q1 | $719K | Sell |
9,783
-800
| -8% | -$61.7K | ﹤0.01% | 848 |
|
|
2022
Q4 | $876K | Sell |
10,583
-345
| -3% | -$27.4K | ﹤0.01% | 796 |
|
|
2022
Q3 | $783K | Buy |
10,928
+912
| +9% | +$78.8K | ﹤0.01% | 820 |
|
|
2022
Q2 | $855K | Buy |
10,016
+1,272
| +15% | +$119K | ﹤0.01% | 822 |
|
|
2022
Q1 | $969K | Hold |
8,744
| – | – | ﹤0.01% | 801 |
|
|
2021
Q4 | $1.11M | Hold |
8,744
| – | – | ﹤0.01% | 795 |
|
|
2021
Q3 | $1.1M | Hold |
8,744
| – | – | ﹤0.01% | 796 |
|
|
2021
Q2 | $984K | Sell |
8,744
-114,592
| -93% | -$12.1M | ﹤0.01% | 804 |
|
|
2021
Q1 | $11.8M | Sell |
123,336
-656
| -0.5% | -$59.8K | 0.02% | 354 |
|
|
2020
Q4 | $9.84M | Sell |
123,992
-2,844
| -2% | -$206K | 0.02% | 367 |
|
|
2020
Q3 | $7.91M | Sell |
126,836
-124,684
| -50% | -$8.11M | 0.01% | 362 |
|
|
2020
Q2 | $16.1M | Buy |
251,520
+125,360
| +99% | +$7.51M | 0.02% | 346 |
|
|
2020
Q1 | $6.06M | Buy |
126,160
+6,232
| +5% | +$312K | 0.01% | 378 |
|
|
2019
Q4 | $6.52M | Buy |
119,928
+152
| +0.1% | +$7.97K | 0.01% | 393 |
|
|
2019
Q3 | $5.96M | Buy |
119,776
+248
| +0.2% | +$12.4K | 0.01% | 405 |
|
|
2019
Q2 | $6.23M | Buy |
119,528
+1,184
| +1% | +$59.7K | 0.01% | 394 |
|
|
2019
Q1 | $5.87M | Buy |
118,344
+24,484
| +26% | +$1.1M | 0.01% | 500 |
|
|
2018
Q4 | $3.4M | Sell |
93,860
-8,560
| -8% | -$358K | 0.01% | 703 |
|
|
2018
Q3 | $5.23M | Buy |
102,420
+18,548
| +22% | +$822K | 0.01% | 538 |
|
|
2018
Q2 | $3.1M | Sell |
83,872
-4,660
| -5% | -$178K | 0.01% | 629 |
|
|
2018
Q1 | $3.34M | Buy |
+88,532
| New | +$3.13M | 0.01% | 534 |
|
Other funds holding TECH
GCM
SIMG
BTCPP
AAM
FWIA
RP
Nordea Investment Management's TECH Position: Q2 2026 in Review
Nordea Investment Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 84,951 shares — an estimated $4.38M sold.
Nordea Investment Management first reported a position in TECH in Q1 2018 and held it in 31 quarters. The position peaked at $16.1M in Q2 2020. 238 funds tracked by Wall St. Rank hold TECH as of Q2 2026.
- Nordea Investment Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
- Nordea Investment Management sold 84,951 Bio-Techne shares in Q2 2026, an estimated $4.38M.
- Nordea Investment Management first reported a position in Bio-Techne in Q1 2018 and held it in 31 quarters.
- Nordea Investment Management's Bio-Techne position peaked at $16.1M in Q2 2020.
- 238 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.